In the first year after diagnosis, when melanoma cancer patients have more frequent visits to the doctors and are more likely to undergo additional medical examinations including PSA testing, prostate cancer risk was only slightly insignificantly elevated. The gene discussed is KLK3; the disease is Familial prostate cancer.